RLAY
Price
$7.63
Change
-$0.44 (-5.45%)
Updated
Jan 15 closing price
Capitalization
1.32B
34 days until earnings call
Intraday BUY SELL Signals
TARA
Price
$5.04
Change
+$0.10 (+2.02%)
Updated
Jan 15 closing price
Capitalization
270.08M
54 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

RLAY vs TARA

Header iconRLAY vs TARA Comparison
Open Charts RLAY vs TARABanner chart's image
Relay Therapeutics
Price$7.63
Change-$0.44 (-5.45%)
Volume$1.9M
Capitalization1.32B
Protara Therapeutics
Price$5.04
Change+$0.10 (+2.02%)
Volume$1.07M
Capitalization270.08M
RLAY vs TARA Comparison Chart in %
RLAY
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
RLAY vs. TARA commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLAY is a Hold and TARA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (RLAY: $7.63 vs. TARA: $5.04)
Brand notoriety: RLAY and TARA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RLAY: 89% vs. TARA: 103%
Market capitalization -- RLAY: $1.32B vs. TARA: $270.08M
RLAY [@Biotechnology] is valued at $1.32B. TARA’s [@Biotechnology] market capitalization is $270.08M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RLAY’s FA Score shows that 1 FA rating(s) are green whileTARA’s FA Score has 1 green FA rating(s).

  • RLAY’s FA Score: 1 green, 4 red.
  • TARA’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than TARA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RLAY’s TA Score shows that 4 TA indicator(s) are bullish while TARA’s TA Score has 3 bullish TA indicator(s).

  • RLAY’s TA Score: 4 bullish, 4 bearish.
  • TARA’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than TARA.

Price Growth

RLAY (@Biotechnology) experienced а -4.62% price change this week, while TARA (@Biotechnology) price change was -10.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +41.99%.

Reported Earning Dates

RLAY is expected to report earnings on Feb 19, 2026.

TARA is expected to report earnings on Mar 11, 2026.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RLAY($1.32B) has a higher market cap than TARA($270M). TARA YTD gains are higher at: -5.441 vs. RLAY (-9.811). TARA has higher annual earnings (EBITDA): -59.43M vs. RLAY (-322.8M). RLAY has more cash in the bank: 596M vs. TARA (133M). TARA has less debt than RLAY: TARA (3.66M) vs RLAY (33.3M). RLAY has higher revenues than TARA: RLAY (8.36M) vs TARA (0).
RLAYTARARLAY / TARA
Capitalization1.32B270M490%
EBITDA-322.8M-59.43M543%
Gain YTD-9.811-5.441180%
P/E RatioN/AN/A-
Revenue8.36M0-
Total Cash596M133M448%
Total Debt33.3M3.66M911%
FUNDAMENTALS RATINGS
TARA: Fundamental Ratings
TARA
OUTLOOK RATING
1..100
2
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
58
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
45

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RLAYTARA
RSI
ODDS (%)
Bearish Trend 3 days ago
85%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
87%
MACD
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 12 days ago
82%
Declines
ODDS (%)
Bearish Trend 5 days ago
89%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
79%
Bullish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
RLAY
Daily Signal:
Gain/Loss:
TARA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FREAX14.550.07
+0.48%
Nuveen Real Estate Securities A
GMEPX29.330.10
+0.34%
Goldman Sachs China Equity P
RDWEX14.610.02
+0.14%
American Funds Dvlpg Wld Gr&Inc R4
MEMGX44.280.02
+0.05%
MFS Emerging Markets Equity R3
MSPRX23.85-0.19
-0.79%
Morgan Stanley Inst Advantage C

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with NRIX. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then NRIX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-5.45%
NRIX - RLAY
52%
Loosely correlated
-0.95%
VIR - RLAY
52%
Loosely correlated
-9.09%
KURA - RLAY
51%
Loosely correlated
-4.81%
IMNM - RLAY
51%
Loosely correlated
+10.07%
BEAM - RLAY
50%
Loosely correlated
-9.49%
More

TARA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARA has been loosely correlated with AMLX. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if TARA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARA
1D Price
Change %
TARA100%
+2.02%
AMLX - TARA
41%
Loosely correlated
-3.91%
IMTX - TARA
40%
Loosely correlated
+0.92%
SYRE - TARA
40%
Loosely correlated
-0.21%
RGNX - TARA
39%
Loosely correlated
-7.96%
RLAY - TARA
38%
Loosely correlated
-5.45%
More